Pfizer-BioNTech uses BC based Acuitas Therapeutics lipid nanoparticle technology.
— Dr. Benjamin Braddock (@GraduatedBen) February 13, 2022
The Trudeau Foundation owns a 40% stake in Acuitas, through both direct ownership of shares and indirect ownership through shell companies.
No comments:
Post a Comment